Cargando…

A Novel Pathogenic Variant in CARMIL2 (RLTPR) Causing CARMIL2 Deficiency and EBV-Associated Smooth Muscle Tumors

CARMIL2 deficiency is a rare combined immunodeficiency (CID) characterized by defective CD28-mediated T cell co-stimulation, altered cytoskeletal dynamics, and susceptibility to Epstein Barr Virus smooth muscle tumors (EBV-SMTs). Case reports associated with EBV-SMTs are limited. We describe herein...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yonkof, Jennifer R., Gupta, Ajay, Rueda, Cesar M., Mangray, Shamlal, Prince, Benjamin T., Rangarajan, Hemalatha G., Alshahrani, Mohammad, Varga, Elizabeth, Cripe, Timothy P., Abraham, Roshini S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314954/ https://www.ncbi.nlm.nih.gov/pubmed/32625199 http://dx.doi.org/10.3389/fimmu.2020.00884

Ejemplares similares

A potential founder variant in CARMIL2/RLTPR in three Norwegian families with warts, molluscum contagiosum, and T‐cell dysfunction
por: Sorte, Hanne S., et al.
Publicado: (2016)

Dual regulation of the actin cytoskeleton by CARMIL-GAP
por: Jung, Goeh, et al.
Publicado: (2022)

A human immunodeficiency syndrome caused by mutations in CARMIL2
por: Schober, T., et al.
Publicado: (2017)

Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency
por: Lévy, Romain, et al.
Publicado: (2022)

Physiological role of the interaction between CARMIL1 and capping protein
por: Edwards, Marc, et al.
Publicado: (2013)

CARMIL family proteins as multidomain regulators of actin-based motility
por: Stark, Benjamin C., et al.
Publicado: (2017)

Novel CARMIL2 Mutations in Patients with Variable Clinical Dermatitis, Infections, and Combined Immunodeficiency
por: Alazami, Anas M., et al.
Publicado: (2018)

Novel CARMIL2 loss-of-function variants are associated with pediatric inflammatory bowel disease
por: Bosa, Luca, et al.
Publicado: (2021)

CARMIL leading edge localization depends on a non-canonical PH domain and dimerization
por: Zwolak, Adam, et al.
Publicado: (2013)

CARMIL2 is a novel molecular connection between vimentin and actin essential for cell migration and invadopodia formation
por: Lanier, M. Hunter, et al.
Publicado: (2015)

Complex Muco-cutaneous Manifestations of CARMIL2-associated Combined Immunodeficiency: A Novel Presentation of Dysfunctional Epithelial Barriers
por: MARANGI, Giuseppe, et al.
Publicado: (2020)

Case report: Primary immunodeficiency due to a novel mutation in CARMIL2 and its response to combined immunomodulatory therapy
por: Zhu, Yu, et al.
Publicado: (2023)

The Dictyostelium Carmil Protein Links Capping Protein and the Arp2/3 Complex to Type I Myosins through Their Sh3 Domains
por: Jung, Goeh, et al.
Publicado: (2001)

Bronchopleural fistula in a 5- years old child with novel CARMIL 2 mutation: A rare disease and a rare case
por: Chaudhry, Ikram ul Haq, et al.
Publicado: (2021)

Capping Protein Regulator and Myosin 1 Linker 3 (CARMIL3) as a Molecular Signature of Ischemic Neurons in the DWI-T2 Mismatch Areas After Stroke
por: Yeh, Shin-Joe, et al.
Publicado: (2021)

Dual T cell– and B cell–intrinsic deficiency in humans with biallelic RLTPR mutations
por: Wang, Yi, et al.
Publicado: (2016)

Acute Myeloid Leukemia Evolving from JAK 2-Positive Primary Myelofibrosis and Concomitant CD5-Negative Mantle Cell Lymphoma: A Case Report and Review of the Literature
por: Treaba, Diana O., et al.
Publicado: (2012)

Loss of Expression of a Novel Chromatin Remodeler SMARCA1 in Soft Tissue Sarcoma
por: Patil, Pallavi A, et al.
Publicado: (2018)

The scaffolding function of the RLTPR protein explains its essential role for CD28 co-stimulation in mouse and human T cells
por: Roncagalli, Romain, et al.
Publicado: (2016)

Claudin Expression in High Grade Invasive Ductal Carcinoma of the Breast: Correlation with the Molecular Subtype
por: Lu, Shaolei, et al.
Publicado: (2012)

MicroRNA Profiling in Mucosal Biopsies of Eosinophilic Esophagitis Patients Pre and Post Treatment with Steroids and Relationship with mRNA Targets
por: Lu, Shaolei, et al.
Publicado: (2012)

Fatal Streptococcus pneumoniae Sepsis in a Patient With Celiac Disease-Associated Hyposplenism
por: Ouseph, Madhu M., et al.
Publicado: (2016)

Inherited TNFSF9 deficiency causes broad Epstein–Barr virus infection with EBV(+) smooth muscle tumors
por: Fournier, Benjamin, et al.
Publicado: (2022)

PD-L1 expression in angiomatoid fibrous histiocytoma
por: Byers, Joshua, et al.
Publicado: (2021)

ADA2 deficiency complicated by EBV-driven lymphoproliferative disease
por: Staples, Emily, et al.
Publicado: (2020)

Epstein Barr virus-associated smooth muscle tumour (EBV-SMT) of the urinary bladder
por: Wood, Dale, et al.
Publicado: (2017)

EBV-Associated Smooth Muscle Neoplasms: Solid Tumors Arising in the Presence of Immunosuppression and Autoimmune Diseases
por: Moore Dalal, Kimberly, et al.
Publicado: (2008)

AIDS-Related EBV-Associated Smooth Muscle Tumors: A Review of 64 Published Cases
por: Purgina, Bibianna, et al.
Publicado: (2011)

SARS-CoV-2 and EBV coinfection()
por: García-Martínez, Francisco Javier, et al.
Publicado: (2020)

EBV & lymphoma
por: Caballero, Dolores
Publicado: (2019)

EBV and Lymphomagenesis
por: Sausen, Daniel G., et al.
Publicado: (2023)

The Role of NK Cells in EBV Infection and EBV-Associated NPC
por: Png, Yi Tian, et al.
Publicado: (2021)

EBV-induced T-cell responses in EBV-specific and nonspecific cancers
por: Zhang, Qiuting, et al.
Publicado: (2023)

EBV-miR-BHRF1-2 targets PRDM1/Blimp1: potential role in EBV lymphomagenesis
por: Ma, J, et al.
Publicado: (2016)

Expression of HSV-1 Receptors in EBV-Associated Lymphoproliferative Disease Determines Susceptibility to Oncolytic HSV
por: Wang, Pin-Yi, et al.
Publicado: (2012)

Editorial: EBV Infection and Human Primary Immune Deficiencies
por: Cohen, Jeffrey I., et al.
Publicado: (2020)

The EBV Gastric Cancer Resource (EBV-GCR): A Suite of Tools for Investigating EBV-Associated Human Gastric Carcinogenesis
por: Salnikov, Mikhail Y., et al.
Publicado: (2023)

Curcuminoids as EBV Lytic Activators for Adjuvant Treatment in EBV-Positive Carcinomas
por: Ramayanti, Octavia, et al.
Publicado: (2018)

The role of EBV-encoded miRNA in EBV-associated gastric cancer
por: Liu, Ting, et al.
Publicado: (2023)

Non-canonical WNT6/WNT10A signal factor expression in EBV+ post-transplant smooth muscle tumors
por: Teiken, Kristin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_pa9uh2da1gj1pk6g8ebj1cshbh